Risk of Cutaneous T Cell Lymphoma with Psoriasis Biologic Therapies

• Hoofdauteurs: Mitchell S. Davis (Auteur), Riley K. Spencer (Auteur), Chandler E. Johnson (Auteur), Kareem G. Elhage (Auteur), Joy Q. Jin (Auteur), Marwa Hakimi (Auteur), Tina Bhutani (Auteur), Wilson Liao (Auteur)
• Formaat: Boek
• Gepubliceerd in: Adis, Springer Healthcare, 2023-12-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Abstract Background The risk of developing cutaneous T cell lymphoma (CTCL) in patients using psoriasis biologics has not been well characterized. The goals of this review were to investigate the incidence of CTCL in patients with psoriasis receiving biologic therapy in clinical trials and psoriasis...